GlassScriptPhysician profile
Brian P Mcvay
NPI 1417155474
$1,423.59
in general payments reported to CMS, 2019-2025
11 companies · $32.00 in 2025
The $32.00 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $41.81 · 2021: $92.01 · 2022: $58.07 · 2023: $907 · 2024: $123 · 2025: $32.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.58 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $813.90 | 2023-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $162.72 | 2021-2024 | Invos, Bis |
| Edwards Lifesciences Corporation | $139.97 | 2019 | |
| Heron Therapeutics, INC. | $121.82 | 2023 | Zynrelef |
| Merck Sharp & Dohme LLC | $54.43 | 2021-2023 | Bridion |
| Pacira Pharmaceuticals Incorporated | $41.81 | 2020 | |
| Davol INC. | $32.00 | 2025 | Phasix Mesh |
| Covidien LP | $29.81 | 2019 | |
| Cvrx, INC. | $20.30 | 2022 | |
| Vyaire Medical, INC. | $6.83 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,120,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mcvay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.